GPC sobre Prevención del Ictus - GuÃaSalud
GPC sobre Prevención del Ictus - GuÃaSalud
GPC sobre Prevención del Ictus - GuÃaSalud
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
555. Bogousslavsky J, Hachinski VC, Boughner DR, Fox AJ, Vinuela F, Barnett HJ.<br />
Cardiac lesions and arterial lesions in carotid transient ischemic attacks. Archives<br />
of Neurology. 1986;43:223-8.<br />
556. Harrison MJG, Marshall J. Atrial fibrillation, TIAs and completed stroke. Stroke.<br />
1984;15:441-2.<br />
557. Koudstaal PJ, van Gijn J, Klootwijk APJ, van der Meche FG, Kappelle LJ, et al.<br />
Holter monitoring in patients with transient and focal ischemic attacks of the brain.<br />
Stroke. 1986;17:192-5.<br />
558. Whisnant JP, Brown RD, Petty GW, O'Fallon WM, Sicks JD, Wiebers DO.<br />
Comparison of population-based mo<strong>del</strong>s of risk factors for TIA and ischemic stroke.<br />
Neurology. 1999;53:532-6.<br />
559. Cerebral Embolism Task Force. Cardiogenic brain embolism. Archives of<br />
Neurology. 1986;43:71-84.<br />
561. Saxena R (a), Koudstaal PJ. Anticoagulants for preventing stroke in patients with<br />
nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack.<br />
Cochrane Database of Systematic Reviews. 2004, Issue 2. Art. No.: CD000185.<br />
562. Saxena R (b), Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing<br />
stroke in patients with nonrheumatic atrial fibrillation and a history of stroke<br />
or transient ischemic attack. Cochrane Database of Systematic Reviews. 2004, Issue<br />
4. Art. No.: CD000187.<br />
563. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in<br />
non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.<br />
Lancet. 1993;342:1255-62.<br />
564. Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Adjusted-dose<br />
warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients<br />
with atrial fibrillation. Lancet. 1996;348:633-8.<br />
565. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. ESC<br />
Committee for Practice gui<strong>del</strong>ines. Gui<strong>del</strong>ines on the management of valvular heart<br />
disease: The Task Force on the Management of Valvular Heart Disease of the<br />
European Society of Cardiology. Eur Heart J. 2007;28(2):230-68<br />
566. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance<br />
of heart valve prostheses. Curr Probl Cardiol. 2000;25:73-154.<br />
567. Roy D, Marchand E, Gagne P, Chabot M, Cartier R. Usefulness of anticoagulant<br />
therapy in the prevention of embolic complications of atrial fibrillation. Am Heart<br />
J. 1986;112:1039-43.<br />
568. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation.<br />
Chest. 1992;102:426S-33S.<br />
569. Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF,<br />
et al. Differences between perspectives of physicians and patients on anticoagulation<br />
in patients with atrial fibrillation: observational study. BMJ. 2001;323:1218-22.<br />
GUÍA DE PRÁCTICA CLÍNICA SOBRE LA PREVENCIÓN PRIMARIA Y SECUNDARIA DEL ICTUS 239
Change language